Details

Autor(en) / Beteiligte

• Shields, Carol L., MD
• Kaliki, Swathi, MD
• Furuta, Minoru, MD
• Fulco, Enzo, MD
• Alarcon, Carolina, MD
• Shields, Jerry A., MD

Titel

American Joint Committee on Cancer Classification of Posterior Uveal Melanoma (Tumor Size Category) Predicts Prognosis in 7731 Patients

Ist Teil von

• Ophthalmology (Rochester, Minn.), 2013-10, Vol.120 (10), p.2066-2071

Ort / Verlag

United States: Elsevier Inc

Erscheinungsjahr

2013

Quelle

MEDLINE

Beschreibungen/Notizen

• Purpose To evaluate the clinical features and prognosis of posterior uveal (ciliary body and choroid) melanoma based on the American Joint Committee on Cancer (AJCC) classification (7th edition) of primary tumor (T). Design Retrospective, interventional case series. Participants Seven thousand seven hundred thirty-one patients. Intervention Ocular management including plaque radiotherapy, enucleation, local resection, or laser therapy. Main Outcome Measures Melanoma-related metastasis and death. Results Of 7731 patients with posterior uveal melanoma, the AJCC classification based on T was category T1 in 3557 (46%), T2 in 2082 (27%), T3 in 1599 (21%), and T4 in 493 (6%). Based on tumor categories T1, T2, T3, and T4, respectively, features that showed significant increase with tumor category included patient age at presentation (57, 58, 58, and 61 years; P <0.001), tumor base (8, 12, 15, and 20 mm; P <0.001), tumor thickness (3.5, 5.2, 8.9, and 11.4 mm; P <0.001), mushroom configuration (8%, 20%, 38%, and 39%; P <0.001), associated subretinal fluid (64%, 80%, 82%, and 83%; P <0.001), intraocular hemorrhage (5%, 12%, 17%, and 18%; P <0.001), rupture of Bruch’s membrane (9%, 24%, 40%, and 40%; P <0.001), and extraocular extension (1%, <1%, 4%, and 12%; P <0.001). After therapy, Kaplan-Meier estimates of metastasis at 5, 10, and 20 years were 8%, 15%, and 25% for category T1, 14%, 25%, and 40% for category T2, 31%, 49%, and 62% for category T3, and 51%, 63%, and 69% for category T4, respectively ( P <0.001). Kaplan-Meier estimates of death at 5, 10, and 20 years were 4%, 8%, and 11% for category T1, 8%, 13%, and 24% for category T2, 19%, 27%, and 36% for category T3, and 30%, 43%, and 51% for category T4, respectively ( P <0.001). Compared with category T1, the hazard ratio for metastasis and death for T2 was 1.8 and 1.9, respectively, that for T3 was 4.5 and 4.7, respectively, and that for T4 was 8.2 and 8.8, respectively. Conclusions Based on the AJCC classification, increasing tumor category was associated with older age, larger tumor, and greater incidence of subretinal fluid, hemorrhage, and extraocular extension. Compared with uveal melanoma classified as T1, the rate of metastasis and death was 2 times greater for T2, 4 times greater for T3, and 8 times greater for T4. The risk for metastasis and death increased 2-fold with each increasing melanoma category. Financial Disclosure(s) The author(s) have no proprietary or commercial interest in any materials discussed in this article.